A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo.
A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo.
复制标题
DOI:
10.1016/j.xcrm.2022.100774
复制
发表时间:
2022-10-18
影响因子:
14.3
通讯作者:
Markovitz, David M.
中科院分区:
文献类型:
--
作者:
Chan, Jasper Fuk-Woo;Oh, Yoo Jin;Yuan, Shuofeng;Chu, Hin;Yeung, Man-Lung;Canena, Daniel;Chan, Chris Chung-Sing;Poon, Vincent Kwok-Man;Chan, Chris Chun-Yiu;Zhang, Anna Jinxia;Cai, Jian-Piao;Ye, Zi-Wei;Wen, Lei;Yuen, Terrence Tsz-Tai;Chik, Kenn Ka-Heng;Shuai, Huiping;Wang, Yixin;Hou, Yuxin;Luo, Cuiting;Chan, Wan-Mui;Qin, Zhenzhi;Sit, Ko-Yung;Au, Wing-Kuk;Legendre, Maureen;Zhu, Rong;Hain, Lisa;Seferovic, Hannah;Tampe, Robert;To, Kelvin Kai-Wang;Chan, Kwok-Hung;Thomas, Dafydd Gareth;Klausberger, Miriam;Xu, Cheng;Moon, James J.;Stadlmann, Johannes;Penninger, Josef M.;Oostenbrink, Chris;Hinterdorfer, Peter;Yuen, Kwok-Yung;Markovitz, David M.
“Pan-coronavirus” antivirals targeting conserved viral components can be designed. Here, we show that the rationally engineered H84T-banana lectin (H84T-BanLec), which specifically recognizes high mannose found on viral proteins but seldom on healthy human cells, potently inhibits Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (including Omicron), and other human-pathogenic coronaviruses at nanomolar concentrations. H84T-BanLec protects against MERS-CoV and SARS-CoV-2 infection in vivo. Importantly, intranasally and intraperitoneally administered H84T-BanLec are comparably effective. Mechanistic assays show that H84T-BanLec targets virus entry. High-speed atomic force microscopy depicts real-time multimolecular associations of H84T-BanLec dimers with the SARS-CoV-2 spike trimer. Single-molecule force spectroscopy demonstrates binding of H84T-BanLec to multiple SARS-CoV-2 spike mannose sites with high affinity and that H84T-BanLec competes with SARS-CoV-2 spike for binding to cellular ACE2. Modeling experiments identify distinct high-mannose glycans in spike recognized by H84T-BanLec. The multiple H84T-BanLec binding sites on spike likely account for the drug compound’s broad-spectrum antiviral activity and the lack of resistant mutants. H84T-BanLec inhibits human-pathogenic coronaviruses through inhibition of viral entry H84T-BanLec protects against MERS-CoV and SARS-CoV-2 infections in vivo H84T-BanLec binds to multiple SARS-CoV-2 spike high-mannose sites with high affinity This unique mechanism likely accounts for H84T-BanLec’s broad-spectrum activity Chan et al. investigate the antiviral activity and mechanism of H84T-BanLec against human-pathogenic coronaviruses. H84T-BanLec possesses pan-coronaviral antiviral activity through inhibition of viral entry and protects against MERS-CoV and SARS-CoV-2 infections in vivo. Binding of H84T-BanLec to multiple high-mannose glycans in spike likely accounts for its lack of resistant mutants.
登录
查看更多内容
影响因子:
13.6
作者:
Farkash, Evan A.;Wilson, Allecia M.;Jentzen, Jeffrey M.
通讯作者:
Jentzen, Jeffrey M.
影响因子:
18.2
作者:
Casalino L;Gaieb Z;Goldsmith JA;Hjorth CK;Dommer AC;Harbison AM;Fogarty CA;Barros EP;Taylor BC;McLellan JS;Fadda E;Amaro RE
通讯作者:
Amaro RE
影响因子:
13.2
作者:
Chan, Jasper Fuk-Woo;Kok, Kin-Hang;Yuen, Kwok-Yung
通讯作者:
Yuen, Kwok-Yung
影响因子:
168.9
作者:
Chan, Jasper Fuk-Woo;Yuan, Shuofeng;Yuen, Kwok-Yung
通讯作者:
Yuen, Kwok-Yung
影响因子:
6.4
作者:
Chan, Jasper Fuk-Woo;Chan, Kwok-Hung;Yuen, Kwok-Yung
通讯作者:
Yuen, Kwok-Yung